MIR516B2: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

Target Name: MIR516B2

NCBI ID: G574485

MIR516B2

MIR516B2: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

MIR516B2 (hsa-miR-516b-3p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a member of the miRNA-516 gene family, which is known for its role in regulating various cellular processes such as cell growth, apoptosis, and inflammation.

MIR516B2 has been shown to play a critical role in the regulation of cell proliferation and survival. It has been shown to inhibit the activity of the oncogene transforming growth factor-尾 (TGF-β), which is a well-known regulator of cell proliferation and transformation.

In addition to its role in cell proliferation, MIR516B2 has also been shown to play a role in the regulation of cell apoptosis. It has been shown to induce cell apoptosis in response to various stimuli, such as exposure to chemotherapy drugs or radiation.

MIR516B2 has also been shown to have anti-inflammatory effects. It has been shown to reduce the production of pro-inflammatory cytokines in response to various stimuli, such as inflammation-promoting drugs or stress.

Due to its potential role in drug targeting and biomarker analysis, MIR516B2 has been the focus of intense research in recent years. Studies have shown that MIR516B2 can be effectively targeted with small molecules, such as inhibitors of the TGF-β signaling pathway.

In addition to its potential as a drug target, MIR516B2 has also been shown to be a valuable biomarker for various diseases. For example, it has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer.

Furthermore, MIR516B2 has also been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion. It has been shown to play a role in the regulation of cell-cell adhesion by interacting with the protein E-cadherin.

In conclusion, MIR516B2 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of cell proliferation, apoptosis, and inflammation. Its potential as a drug target or biomarker makes it an attractive target for further research in the field of cancer and other diseases.

Protein Name: MicroRNA 516b-2

The "MIR516B2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR516B2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets